66 results match your criteria: "Silesian Heart Center[Affiliation]"

Article Synopsis
  • Left atrial appendage closure (LAAC) during heart surgery for atrial fibrillation (AF) patients may lower long-term stroke risk and mortality, but mixed evidence exists regarding its effectiveness in non-AF patients.
  • A review of 25 studies indicated that while LAAC reduced early stroke risk by 19% and late stroke risk by 13%, it showed no advantages for patients without AF.
  • Overall, LAAC appears beneficial in patients with preoperative AF, suggesting it could reduce long-term mortality and stroke rates, but there’s insufficient evidence to recommend it for those without AF.
View Article and Find Full Text PDF

Comparative Analysis of Long-Term Outcomes in Valve-Sparing Aortic Root Reimplantation: Full Sternotomy versus Mini-Sternotomy Approach.

J Clin Med

May 2024

Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior and Administration, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland.

Aortic valve-sparing aortic root replacement (VSARR) David procedure has not been routinely performed via minimally invasive access due to its complexity. We compared our results for mini-VSARR to sternotomy-VSARR from another excellence center. Eighty-four patients, 62 in the sternotomy-VSARR group and 22 in the mini-VSARR group, were included.

View Article and Find Full Text PDF

Despite evidence suggesting the benefit of prophylactic regional antibiotic delivery (RAD) to sternal edges during cardiac surgery, it is seldom performed in clinical practice. The value of topical vancomycin and gentamicin for sternal wound infections (SWI) prophylaxis was further questioned by recent studies including randomized controlled trials (RCTs). The aim of this systematic review and meta-analysis was to comprehensively assess the safety and effectiveness of RAD to reduce the risk of SWI.

View Article and Find Full Text PDF

Additional bypass graft or concomitant surgical ablation? Insights from the HEIST registry.

Surgery

April 2024

Clinical Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior and Administration, Centre of Postgraduate Medical Education, Warsaw, Poland; Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT, Palermo, Italy; Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, the Netherlands; Thoracic Research Centre, Collegium Medicum Nicolaus Copernicus University, Innovative Medical Forum, Bydgoszcz, Poland. Electronic address:

Background: Surgical ablation for atrial fibrillation at the time of isolated coronary artery bypass grafting is reluctantly attempted. Meanwhile, complete revascularization is not always possible in these patients. We attempted to counterbalance the long-term benefits of surgical ablation against the risks of incomplete revascularization.

View Article and Find Full Text PDF

Objectives: The aim of this study was to evaluate in-hospital outcomes and long-term survival of patients undergoing cardiac surgery with preoperative atrial fibrillation (AF). We compared different strategies, including no-AF treatment, left atrial appendage occlusion (LAAO) alone, concomitant surgical ablation (SA) alone or both.

Methods: A retrospective analysis using the KROK registry included all patients with preoperative diagnosis of AF who underwent cardiac surgery in Poland between between January 2012 and December 2022.

View Article and Find Full Text PDF

Impact of COVID-19 on incidence and outcomes of post-infarction mechanical complications in Europe.

Interdiscip Cardiovasc Thorac Surg

December 2023

Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, Netherlands.

Objectives: Post-acute myocardial infarction mechanical complications (post-AMI MCs) represent rare but life-threatening conditions, including free-wall rupture, ventricular septal rupture and papillary muscle rupture. During the coronavirus disease-19 (COVID-19) pandemic, an overwhelming pressure on healthcare systems led to delayed and potentially suboptimal treatments for time-dependent conditions. As AMI-related hospitalizations decreased, limited information is available whether higher rates of post-AMI MCs and related deaths occurred in this setting.

View Article and Find Full Text PDF

Surgical intervention in the setting of cardiogenic shock (CS) is burdened with high mortality. Due to acute condition, detailed diagnoses and risk assessment is often precluded. Atrial fibrillation (AF) is a risk factor for perioperative complications and worse survival but little is known about AF patients operated in CS.

View Article and Find Full Text PDF

Background: Stereotactic arrhythmia radioablation (STAR) is delivered with a planning target volume (PTV) prescription dose of 25 Gy, mostly to the surrounding 75-85% isodose line. This means that the average and maximum dose received by the target is less than 35 Gy, which is the minimum threshold required to create a homogenous transmural fibrosis. Similar to catheter ablation, the primary objective of STAR should be transmural fibrosis to prevent heterogenous intracardiac conduction velocities and the occurrence of sustained ventricular arrhythmias (sVA) caused by reentry.

View Article and Find Full Text PDF

Robots are defined as programmable machines that can perform specified tasks. Medical robots are emerging solutions in the field of cardiology leveraging recent technological innovations of control systems, sensors, actuators, and imaging modalities. Robotic platforms are successfully applied for percutaneous coronary intervention, invasive cardiac electrophysiology procedures as well as surgical operations including minimally invasive aortic and mitral valve repair, coronary artery bypass procedures, and structural heart diseases.

View Article and Find Full Text PDF
Article Synopsis
  • - This study investigated the safety and effectiveness of stereotactic arrhythmia radioablation (STAR) for treating ventricular tachycardia (VT) in patients who didn't respond to traditional catheter ablation or had contraindications to it.
  • - In a group of 11 patients, the trial monitored for severe adverse events, finding that only one patient experienced a significant treatment-related issue, while the others showed an 84.3% reduction in VT symptoms.
  • - While STAR shows promise as a safe treatment option for certain patients, further research is needed to evaluate long-term effects and to compare it with existing treatment methods.
View Article and Find Full Text PDF

The study aimed to validate the European System for Cardiac Operative Risk Evaluation score (EuroSCORE II) in patients with atrial fibrillation (AF). All data were retrieved from the National Registry of Cardiac Surgery Procedures (KROK). EuroSCORE II calibration and discrimination performance was evaluated.

View Article and Find Full Text PDF
Article Synopsis
  • Routine use of topical vancomycin after cardiac surgery is often overlooked, despite it being recommended in guidelines and questioned in recent trials for its effectiveness against sternal wound infections.
  • An analysis of 20 studies, including both randomized controlled trials and observational studies, showed that topical vancomycin reduced the risk of sternal wound infections by nearly 70%, with benefits seen for both superficial and deep infections.
  • The treatment's effectiveness was particularly pronounced in patients with diabetes, and no resistance to vancomycin or methicillin was found, leading to a significant decrease in gram-negative cultures as well.
View Article and Find Full Text PDF

Background: While tackling moderate tricuspid regurgitation (TR) simultaneously with left-side heart surgery is recommended by the guidelines, the procedure is still seldom performed, especially in the minimally invasive setting. Atrial fibrillation (AF) is a known marker of both mortality and TR progression after mitral valve surgery.

Aims: This study aimed to investigatev the safety of performing tricuspid intervention and minimally invasive mitral valve surgery (MIMVS) in patients with preoperative AF.

View Article and Find Full Text PDF

Background: Referral and admission echocardiography (ECHO) in patients scheduled for aortic valve replacement (AVR) with aortic stenosis (AS) may differ in the assessment of moderate functional mitral regurgitation (FMR).

Aims: Our study aimed to determine truly moderate FMR and evaluate its impact on survival.

Methods: We conducted an observational study of patients referred for AVR with AS and no, mild, or moderate FMR between 2014 and 2019.

View Article and Find Full Text PDF
Article Synopsis
  • Transcatheter aortic valve implantation (TAVI) is an alternative to traditional surgery for patients with aortic stenosis, with new valve designs like Medtronic's Evolut PRO aiming to improve patient outcomes.
  • A systematic review and meta-analysis compared the new Evolut PRO valve with its predecessor, the Evolut R, using data from 11 studies involving over 12,000 patients.
  • Findings revealed that both valves had similar overall outcomes, but the Evolut PRO significantly reduced the risk of moderate-to-severe paravalvular leaks and major bleeding compared to the Evolut R.
View Article and Find Full Text PDF

Objectives: Transcatheter aortic valve implantation (TAVI) remains the preferred strategy for high-risk or elderly individuals with aortic valve (AV) stenosis who are not considered to be optimal surgical candidates. Recent evidence suggests that low-risk patients may benefit from TAVI as well. The current study evaluates midterm survival in low-risk patients undergoing elective surgical AV replacement (SAVR) versus TAVI.

View Article and Find Full Text PDF

Background: Atrial fibrillation (AF) is a relatively common comorbidity among patients referred for coronary artery bypass grafting (CABG) and is associated with poorer prognosis. However, little is known about how surgical technique influences survival in this population.

Aim: The current analysis aimed to determine whether total arterial revascularization (TAR) is associated with improved long-term outcomes in patients with preoperative AF.

View Article and Find Full Text PDF

Atrial fibrillation ablation improves late survival after concomitant cardiac surgery.

J Thorac Cardiovasc Surg

December 2023

Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior, Centre of Postgraduate Medical Education, Warsaw, Poland; Thoracic Research Centre, Collegium Medicum Nicolaus Copernicus University, Innovative Medical Forum, Bydgoszcz, Poland.

Objective: Preoperative atrial fibrillation (AF) increases risk of stroke, heart failure, and all-cause mortality after cardiac surgery. Despite encouraging results and guideline recommendations, surgical ablation (SA) for AF concomitant with other heart surgery remains low. In the current study we aimed to address the long-term mortality after SA concomitant with cardiac surgery.

View Article and Find Full Text PDF

Cardiac stereotactic body radiotherapy is an emerging treatment method for recurrent ventricular tachycardia refractory to invasive treatment methods. The single-fraction delivery of 25 Gy was assumed to produce fibrosis, similar to a post-radiofrequency ablation scar. However, the dynamics of clinical response and recent preclinical findings suggest a possible different mechanism.

View Article and Find Full Text PDF

Objectives: Although endorsed by international guidelines, complete revascularization (CR) with Coronary Artery Bypass Grafting (CABG) remains underused. In higher-risk patients such as those with pre-operative atrial fibrillation (AF), the effects of CR are not well studied.

Methods: We analyzed patients' data from the HEIST (HEart surgery In AF and Supraventricular Tachycardia) registry.

View Article and Find Full Text PDF